Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: Evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-γ

Scandinavian Journal of Immunology

Volumn 46, Issue 6, 1997, Pages 625-632

  Seliger, B ^a   Dunn, T ^b,c   Schwenzer, A ^a   Casper, J ^b   Huber, C ^a   Schmoll, H J ^b,c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; EMBRYONAL CARCINOMA; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SYNTHESIS REGULATION;

EID: 0031468363     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-176.x     Document Type: Article

References (58)

1. Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 1989;7:601-24.
2. Goldberg AL, Rock KL. Proteolysis, proteasomes and antigen presentation. Nature 1992;357:375-9.
3. Yewdell JW, Bennink JR. Cell biology of antigen processing and presentation to MHC class I molecule-restricted T lymphocytes. Annu Rev Immunol 1992;52:1-123.
4. Glynne R, Powis SH, Beck S, Kelly LA, Kerr I, Trowsdale J. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 1991;353:357-60.
5. Ortiz-Navarette V, Seelig A, Gernold M, Frentzel S, Kloetzel PM, Hämmerling HG. Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex. Nature 1991;353:663-5.
6. Monaco JJ, Cho S, Attaya M. Transport protein genes in the murine MHC: possible implications for antigen processing. Nature 1990; 250:1723-6.
7. Spies T, Breshnahan M, Bahram S, Arnold D, Blanck G, Mellins E, Pious D, DeMars R. A gene in the major histocompatibility complex class I region controlling the class I antigen presentation pathway. Nature 1990;348:744-7.
8. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A. Sequences encoded in the class I region of the MHC related to the 'ABC' superfamily of transporters. Nature 1990;348:741-4.
9. Momburg F, Roelse J, Neefjes J, Hämmerling HG. Peptide transporters and antigen processing. Behr Inst Mitt 1994;24:26-36.
10. Neefjes JJ, Momburg F, Hämmerling HG. Selective and ATP-dependent translocation of peptides by MHC-encoded transporter. Science 1993;261:769-71.
11. Heemels MT, Schumacher TNM, Wonigeit K, Ploegh HL. Peptide translocation by variants of the transporter associated with antigen processing. Science 1993;262:2059-63.
12. Cerundolo VJ, Alexander J, Anderson K, Lamb C, Cresswell P, McMichael A, Gotchi F, Townsend A. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature 1990;334:449-52.
13. Hosken NA, Bevan MJ. An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S. J Exp Med 1992; 175:719-23.
14. +T cells. Cell 1992;71:1205-14.
15. Fehling HJ, Swat W, Laplace C, Kuhn R, Rajewsky K, Müller U, von Boehmer H. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 1994;265:1234-7.
16. Zhou X, Momburg F, Liu T, Abdel-Motal UM, Jondal M, Hämmerling GJ, Ljunggren HG. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP-2 and LMP-7 deficient cells. Eur J Immunol 1994;24:1863-8.
17. Spies T, DeMars R. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 1991;351:323-4.
18. Seliger B, Höhne A, Jung D, Kallfelz M, Knuth A, Jaeger E, Bernhard H, Momburg F, Tampé R, Huber C. Expression and function of the peptide transporters in escape variants of human renal cell carcinomas. Exp Hematol 1997;25:608-14.
19. Mausdley DJ, Pond JS. Modulation of MHC antigen expression by viruses and oncogenes. Immunol Today 1991;12:429-31.
20. Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern PL. Natural history of HLA expression during tumour development. Immunol Today 1993;14:491-9.
21. Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 1995;16:487-94.
22. Ting JP, Baldwin AS. Regulation of MHC expression. Cur Opin Immunol 1993;5:8-16.
23. 2-In gene expression. J Clin Invest 1991;87:284-92.
24. Seliger B, Pfizenmaier K. Post-transcriptional downregulation of MHC class I expression in oncogene-transformed cells is reverted by IFN-alpha and -gamma. J Immunogenet 1989;16:315-20.
25. Restifo NP, Esquivel F, Kawakami Y, Yewdell JW, Mule J, Rosenberg SA, Bennink JR. Identification of human cancers deficient in antigen processing. J Exp Med 1993;177:265-72.
26. Rotem-Yeduhar R, Winograd S, Sela S, Coligan JE, Ehrlich R. Downregulation of peptide transporter genes in cell lines transformed with highly oncogenic adenovirus 12. J Exp Med 1994; 180:477-88.
27. Seliger B, Maeurer MJ, Ferrone S. TAP off - tumors on. Immunol Today 1997;18:292-9.
28. Epperson DE, Arnold D, Spies T, Cresswell P, Pober JS, Johnson DR. Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. J Immunol 1992;149:3297-301.
29. Yang Y, Waters JB, Früh K, Pettersson PA. Proteasomes are regulated by Interferon-γ: Implications for antigen processing. Proc Natl Acad Sci USA 1992;89:4928-32.
30. Seliger B, Hammers S, Höhne A, Zeidler R, Knuth A, Gerharz CD, Huber C. IFN-g mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma. Clin Cancer Res 1997;3:573-8.
31. 2-microglobulin in F9 teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981;78:5754-8.
32. Andrews PW, Bronson DL, Wiles MV, Goodfellow P. The expression of MHC antigens by human teratocarcinoma derived cell lines. Tissue Antigens 1981;17:493-500.
33. Miyazaki JI, Appella E, Ozato K. Negative regulation of the major histocompatibility class I gene in undifferentiated embryonal carcinoma cells. Proc Natl Acad Sci USA 1986;83:9537-41.
34. Silverman T, Rein A, Orrison B, Langloss B, Bratthauer G, Miyazaki JI, Ozato K. Establishment of cell lines from somite stage mouse embryos and expression of major histocompatibility complex class I genes in these cells. J Immunol 1988;140:4378-87.
35. Noun AME, Hussain RF, Oliver TD, Handy AM, Bartkova I, Bodmer JG. Immunological paradox in testicular tumors: the presence of a large number of activated T-cells despite the complete absence of MHC antigens. Eur J Cane 1993;13:1895-9.
36. Rosenthal SA, Wright S, Cedar H, Flavell RA, Grosveld F. Regulated expression of an introduced MHC H-2Kbm1 gene in murine embryonal carcinoma cells. Nature 1984;310:415-18.
37. Segars JH, Nagata T, Bours V, Medin JA, Franzozo G, Blanco JC, Drew P, Becker K, An J, Tang T, Stephany DA, Neel B, Siebenlist U, Ozato K. Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-κB (p50-p65) and retinoic acid receptor β-retinoid X receptor heterodimers. Mol Cell Biol 1993;13:6157-69.
38. Harada H, Willison J, Sukakibara J, Miyamoto M, Fujita T, Taniguchi T. Absence of the type I INF system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell 1990;63:303-12.
39. Ostrand-Rosenberg S, Schwartzman ML, Hecht TT, Marr L. Terato-carcinoma cell MHC antigen expression is regulated in vitro by a soluble noninterferon factor. Cell Immunol 1986;99:453-60.
40. Ozato K, Wan L, Orsin B. Mouse major histocompatibility class 1 gene expression begins at the midsomite stage and is inducible in earlier stage embryos by interferon. Proc Natl Acad Sci USA 1985; 82:2427-31.
41. Bikoff E, Jaffe L, Ribaudo RK, Otten GR, Germain RN, Robertson EJ. MHC class I surface expression in embryo-derived cell lines inducible with peptide or Interferon. Nature 1991a;354:235-8.
42. Bikoff EK, Otten GR, Robertson EJ. Defective assembly of class 1 major histocompatibility complex molecules in an embryonic cell line. Eur J Immunol 1991;21:1997-2004.
43. Wang Z, Hu X, Tatake RJ, Yang SY, Zeff RA, Ferrone S. Differential effect of human and mouse beta-2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta-2-microgobulin gen-null melanoma cells. Cancer Res 1993;53:4302-9.
44. Andrews PW, Bronson DJ, Benham F, Strickland S, Knowles BB. A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int J Cancer 1980;26:269-80.
45. Riberdy JM, Cresswell P. The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation. J Immunol 1992;148:2586-90.
46. Ljunggren HG, Kärre K. Host resistance directed selectively against H2 deficient lymphoma variants. J Exp Med 1985;162:1745-59.
47. Früh K, Yang Y, Arnolds D, Chambers J, Wu L, Waters JB, Spies T, Peterson PA. Alternative exon usage and processing of the major histocompatibility complex-encoded proteasome subunits. J Biol Chem 1992;267:22131-4.
48. Ponte P, Ng S, Engel J, Gunning P, Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNS. Nucl Acids Res 1984;12: 1687-96.
49. Koller BH, Orr HT. Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level. J Immunol 1985;134:2727-33.
50. Chirgwin JM, Przybyla AA, MacDonald RJ, Rutter WJ. Isolation of biological active ribonucleic acid from sources enriched in ribonuclease. Biochem 1979;18:5294-9.
51. Brodsky FM, Parham P, Barn JC, Crumpton MJ, Bodmer WF. Characterization of a monoclonal antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur J Immunol 1979;9:536-45.
52. Meyer TH, van Endert PM, Uebel S, Ehring B, Tainpé R. Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Lett 1994;351:443-7.
53. Mason MD, Pera MF. Immunohistochemical and biochemical characterisation of the expression of a human embryonal carcinoma cell proleoglycan antigen in human germ cell tumors and other tissues. Eur J Cancer 1992;28:1090-8.
54. Henderson R, Michel H, Sakaguchi K, Shabanowitz J, Appella E, Hunt DF, Engelhard VH. HLA-A2.1 associated peptides from mutant cell lines: a second pathway of antigen presentation. Science 1992;255:1264-8.
55. Schirmbeck R, Reimann J. Peptide transporter independent, stress protein mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation. Eur J Immunol 1994;24:1478-83.
56. Flanagan JR, Murata M, Burke PA, Shirayoshi Y, Appella E, Sharp PA, Ozato K. Negative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells. Proc Natl Acad Sci USA 1991;88:3145-9.
57. Wright KL, White LC, Kelly A, Beck S, Trowsdale J, Ting JPY. Coordinate regulation of the human TAP-1 and LMP-2 genes from a shared bidirectional promoter. J Exp Med 1995;181:1459-71.
58. Gaczynska M, Rock KL, Goldberg AL. Interferon-gamma and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 1993;365:264-7.